To develop a risk prediction model to preoperatively discriminate
between benign, borderline, stage I invasive, stage II-IV invasive, and
secondary metastatic ovarian tumours.
0
comments
:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.